Promising
Oxytocin (Intranasal)
The prediction game
Call it: rising or fading?
Where does Oxytocin (Intranasal) stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: C (mixed evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.5/10
Intranasal oxytocin lands at Neutral because it pairs an outstanding safety record with genuinely inconsistent efficacy for the very uses it is marketed for. If you are curious, even-keeled, and want a low-risk, low-cost acute experiment for connection or social ease in a specific moment, it is a reasonable thing to try, provided you can source clean compounded material and go in expecting a subtle or possibly absent effect. If you are looking for a reliable, evidence-backed treatment for autism, anxiety, or low libido, the honest read is that the best evidence does not support it: the largest therapeutic trial was null, per Sikich 2021, and the founding trust finding did not replicate, per Nave 2015. Think of it as real but oversold, and very safe to test. ✅ Best for: Curious, even-keeled people who want a one-off experiment for connection or social ease before a date, event, or hard conversation. People who can source clean compounded oxytocin rather than a sketchy grey-market vial. Those who accept the brain delivery is slow and dose 45 to 75 minutes ahead. Anyone who will judge it honestly on their own response over a few tries, since the non-response group is large. People drawn to its endogenous nature and clean safety record who want the lowest-risk entry point into social-peptide experimentation. ❌ Avoid if: You expect a reliable love drug or a guaranteed mood lift, because the marketed effects are inconsistent and the famous trust finding failed to replicate, per Nave 2015. You are treating autism and want evidence-backed help, since the largest trial was null, per Sikich 2021. You want a dependable libido tool, where the melanocortin pathway behind PT-141 has more direct data. You cannot verify source quality, because peptide purity and potency vary widely and a degraded vial does nothing. You are inclined to use it daily, given the unquantified desensitization question and the lack of any cumulative benefit.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 0.3%
- BioHarmony Score
- 6.5/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.